Natural Capsules Limited

BSE:524654 Stock Report

Market Cap: ₹2.9b

Natural Capsules Past Earnings Performance

Past criteria checks 2/6

Natural Capsules has been growing earnings at an average annual rate of 18.2%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 21.8% per year. Natural Capsules's return on equity is 0.8%, and it has net margins of 1.3%.

Key information

18.2%

Earnings growth rate

11.2%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate21.8%
Return on equity0.8%
Net Margin1.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Natural Capsules makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:524654 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,606221380
30 Jun 241,569431340
31 Mar 241,554561290
31 Dec 231,528721200
30 Sep 231,5831131170
30 Jun 231,6591511150
31 Mar 231,7241841120
31 Dec 221,7632091100
30 Sep 221,6841971080
30 Jun 221,536170990
31 Mar 221,3511391010
31 Dec 211,166104990
30 Sep 211,00879940
30 Jun 2189265890
31 Mar 2179569830
31 Dec 2072054790
30 Sep 2066740780
30 Jun 2063530760
31 Mar 206169750
31 Dec 1961717800
30 Sep 1960717760
30 Jun 1959518750
31 Mar 1959819740
31 Dec 1855918690
30 Sep 1854721680
30 Jun 1857822640
31 Mar 1854811670
31 Dec 175854560
30 Sep 175843560
30 Jun 175352590
31 Mar 175366620
31 Dec 1654211670
30 Sep 1654412680
30 Jun 1657725660
31 Mar 1662143660
31 Dec 156434815410
30 Sep 156725915110
30 Jun 156715714910
31 Mar 1567356600
31 Dec 14669531248
30 Sep 14638531218
30 Jun 14613491198
31 Mar 14585461188
31 Dec 13558651007

Quality Earnings: 524654 has high quality earnings.

Growing Profit Margin: 524654's current net profit margins (1.3%) are lower than last year (7.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 524654's earnings have grown by 18.2% per year over the past 5 years.

Accelerating Growth: 524654's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 524654 had negative earnings growth (-80.9%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.4%).

Return on Equity

High ROE: 524654's Return on Equity (0.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:11
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Natural Capsules Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research